par Tsukamoto, Katsura;Cnop, Miriam
;Mori, Daichi;Kume, Shoen;Anazawa, Takayuki;Doi, Masako;Chikazawa, Kazuhiko;Matsumaru, Naoki
Référence Therapeutic Innovation and Regulatory Science, 53, 4, page (535-541)
Publication Publié, 2019-07-01
;Mori, Daichi;Kume, Shoen;Anazawa, Takayuki;Doi, Masako;Chikazawa, Kazuhiko;Matsumaru, NaokiRéférence Therapeutic Innovation and Regulatory Science, 53, 4, page (535-541)
Publication Publié, 2019-07-01
Article révisé par les pairs
| Résumé : | The number of diabetes patients is steadily increasing worldwide. Consequently, the social burden of diabetes is huge, requiring urgent countermeasures. We performed an intensive survey of antidiabetic drugs approved in Japan, the United States, and the European Union. |



